Lucid Korea, which has been focusing on ophthalmology, attaches great importance to the combination of basic ophthalmology research and product development. Relying on nearly 20 years of painstaking accumulation, excellent continuous innovation ability and almost strict quality management, Lucid series products have been sold well in the Korean market for many years, and the market share of hard mirror products has exceeded 45%, which has undoubtedly become the leading brand in the field of ophthalmology in Korea.
Lucid Korea has formed a clear orthokeratology (Ortho-KLK&; Reg- lens), clear orthokeratology astigmatism (orthok-lk&; Reg- toric lens), RGP Lucid rigid oxygen permeable contact lens (RGP Lucid Extra/Advance), RGP Lucid keratoconus (YK Lucid-Lens), Lucid IOL/CTR, etc. , and it is the only company in Korea that produces intraocular lenses and intraocular lens rings.
Lucid Korea's excellent R&D and innovation capabilities have been highly concerned and supported by Korean state institutions and departments, and many of its products have been supported by Korean state institutions and departments. Among them, transparent orthokeratology, transparent orthokeratology astigmatism, transparent keratoconus RGP and intraocular lens belong to the long-term key support projects of Korea's Ministry of Knowledge Economy, Ministry of Health and Welfare, Small and Medium-sized Enterprises Office and other national institutions.
Relying on R&D's nearly rigorous system capability, patent, production and clinical services. In July, 2009, Korean LUCID aspherical external lens was approved by China State Food and Drug Administration to enter China (No.3221688, 2009); 20111February, Korean LUCID orthokeratology mirror was approved by China State Food and Drug Administration to enter China (No.3224026).